Chicago-based start-up Tempus has raised $200m from investors including Novo Holdings and Revolution Growth, and gained a valuation of $3.1bn. Tempus, created by Eric Lefkofskyfounder Groupon co-, gathers and analyses clinical and molecular information for a database that will enable more precise health care. The company said the latest investment will enable it to expand its focus from cancer to conditions including depression and diabetes.
Chicago-based start-up Tempus has raised $200m from investors including Novo Holdings and Revolution Growth, and gained a valuation of $3.1bn. Tempus, created by Groupon co-founder Eric Lefkofsky, gathers and analyses clinical and molecular information for a database that will enable more precise health care. The company said the latest investment will enable it to expand its focus from cancer to conditions including depression and diabetes.